Tag: Clinical Study

Samsung Bioepis Announced Findings of 3-Year Study

Samsung Bioepis Co., Ltd. announced findings of a three-year follow-up study comparing biosimilar ONTRUZANT® (trastuzumab) and reference medicine trastuzumab in early or locally advanced HER2-positive...

BioArctic Started Clinical Study for Parkinon’s Treatment

BioArctic AB announced that the first clinical study with ABBV-0805 has started in the U.S. AbbVie is responsible for the clinical development of ABBV-0805. The Phase 1 study in healthy volunteers wil...

Bayer Clinical Study of Tropical Disease Treatment Met Endpoint

Largest clinical treatment study to date in pediatric patients with Chagas disease. Bayer today presented the results of the CHICO (CHagas disease In Children treated with NifurtimOx) phase III cli...

Celgene Cancer Treatment Therapy Not Reach Endpoint

Top-line results announced from the international Phase 3 study evaluating adjuvant therapy with ABRAXANE in combination with gemcitabine vs. gemcitabine alone for patients with surgically resected pa...

Second Positive Phase 3 of NSCLC Treatment by Lilly Drug

Global, randomized, placebo-controlled study confirms CYRAMZA, in combination with erlotinib, significantly delayed disease progression in previously untreated patients with metastatic non-small cell ...

Significant Improvements in Two Phase 3 of Vertex СF Treatment

Vertex plans to seek global regulatory approvals for either VX-659 or VX-445 triple combination regimen in both F/F and F/MF patient populations concurrently based on final 24-week data for both regim...

Novartis Psoriasis Drug Shows High Results First Time in China

Results strengthen unique position of Cosentyx as a rapid and long-lasting complete treatment of psoriatic disease, with over 200,000 patients treated worldwide. Novartis announced today new data i...

First Human Study of Pill Designed to Replace Injections

Safety and tolerability of RaniPill™ Capsule in humans advances oral delivery of injectable biologic drugs. The first human study of a pill designed to replace injections of biologics is today bein...

Swiss–Georgian Partnership

Clinerion will offer its services to hospitals in Georgia, bringing them access to international clinical studies and the use of Patient Network Explorer for academic research. Georgian Medical Softwa...

First Dose of Inovio’s dMAb™ Technology

Inovio Pharmaceuticals, Inc. in collaboration with The Wistar Institute and the University of Pennsylvania announced that the first subject was dosed as part of the first-ever human study of Inovio's ...

Newron Completed Patient Enrollment in STARS Study

Newron Pharmaceuticals S.p.A., a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system, announced the successf...